Introduction {#S1}
============

Otosclerosis (OTSC) is the single most common cause of hearing impairment among white adults with a prevalence of 0.3-0.4% in the European population [@R01]. Otosclerosis is characterized by bone dystrophy localised to the otic capsule and isolated endochondral bone sclerosis with alternating phases of bone resorption and formation: mature lamellar bone is removed by osteoclasts and replaced by osteoblasts with a thicker, more vascular bone.

Conductive hearing loss develops when otosclerotic foci invade the stapedio-vestibular joint (oval window) and interfere with free motion of the stapes, but about 10% of affected subjects develop profound neurosensorial hearing loss across all frequencies [@R02].

Mean age of onset is between the third decade, and 90% of affected individuals are under 50 years of age at the time of diagnosis. The aetiology of otosclerosis is unknown, although several theories have been postulated. For the familiar forms, which present a dominant form of transmission with reduced penetrance eight loci have been identified: OTSC1 (15q25-26) (OMIM 166800), OTSC2 (7q34-36) (OMIM 605727), OTSC3 (6p21.2-22.3) (OMIM 608244), OTSC4 (16q21-23.2) (OMIM 611571), OTSC5 (3q22-24) (OMIM 608787), OTSC7 (6q13-16.1) (OMIM 611572), OTSC8 (9p13.1-9q21.11) (OMIM 612096) and OTSC10 (1q41-44), but no causative gene has been yet identified [@R03]^-^[@R10]. Moreover, in the last years several association studies have been performed and have suggested the implication of single nucleotide polymorphisms (SNPs) present in several genes in otosclerosis aetiology [@R11]^-^[@R15]. For some genes the results are controversial.

In particular, an interesting and controversial case is represented by the *reelin (RELN)* gene which was associated in some populations, but not in others [@R14] ^16-18^. The *RELN* gene, located on chromosome 7q22.1 and encoding the extracellular matrix protein reelin, is expressed by neural tissues [@R19] [@R20]. The results regarding *reelin* expression in the inner ear and in human stapes footplates are also controversial [@R14] [@R21], making the aetiologic role of *RELN* in the pathogenesis of otosclerosis unclear. In previous studies, among the identified single nucleotide polymorphisms (SNPs) in *RELN* gene, the rs39335 variant was one of the most promising [@R16] [@R17]. In order to add information about a possible role of *RELN* in the aetiology of otosclerosis, we performed a case-control association study in a southern Italian population for the SNP rs39335.

Materials and methods {#S2}
=====================

Patient selection {#S2a}
-----------------

A total of 92 otosclerotic subjects were recruited by clinical centres present in Naples (Audiology and Othorhinolaryngology Units of University of Naples \"Federico II\"; Othorhinolaryngology Unit of \"C. Ascalesi\" Hospital, Naples, Italy). Subjects (65 females and 27 males) were all unrelated: age range 30-50 years. For 51 patients, clinical diagnosis was based on surgical findings during stapes surgery, while for the 41 remaining patients was based on audiological data [@R22] [@R23]. The control group was composed of 92 healthy individuals. Affected and control subjects are all originated from the Campania region. Written informed consent was obtained from all participants for DNA analysis according to the principles of the Helsinki Declaration.

SNP analysis and genotyping {#S2b}
---------------------------

Genomic DNA was extracted by conventional salt precipitation protocols from peripheral blood samples obtained in EDTA-containing tubes. For genotyping the rs39335 SNP in *RELN* the following primers were used (RELN1F 5\'-GTCAATGATGAGGATGTTAATGTATA and RELN1R 5\'-GAGAGAGACTAGCCAGAGGATC-3\'): the RELN1F primer introduces a recognition site for the restriction enzyme Bstz17I. The primer pairs was designed using the PIRA PCR programme at <http://cedar.genetics.soton.ac.uk/public_html/primer2.html>. To amplify the region of interest in *RELN*, a polymerase chain reaction (PCR) was performed using 50 ng of purified genomic DNA in a PCR mix containing 10X Buffer II, 25 mM MgCl2, 5 U/μl Ampli Taq Gold; (Applied Biosystems) in the presence of 2.5 mM deoxynucleotide triphospate (dNTP) and 25 mM primers. For the *RELN* gene PCR was carried out with an initial denaturation cycle of 95°C for 10 min, 38 cycles with denaturation at 95°C for 1 min, annealing at 54°C for 1 min, elongation at 72°C for 1 min, and finally elongation at 72°C for 10 min. PCR products were digested overnight at 37°C according to the manufacturer\'s instructions.

Statistical analysis {#S2c}
--------------------

The association of the rs39335 SNP with otosclerosis was analyzed by an exact chi-square test, comparing SNP frequencies using the software FINETTI (<http://ihg2.helmholtz-muenchen.de>.). Hardy-Weinberg equilibrium (HWE) of tested groups and Amirtage\'s trend test (ATT) as well as allele and genotype frequencies and odds ratios were also calculated using the FINETTI software.

Significant differences were considered to be when p \< 0.05. Genotype and allele frequencies were compared between the two groups (otosclerotic subjects and healthy controls).

Results {#S3}
=======

Case-control analysis for the SNP rs39335 {#S3a}
-----------------------------------------

To add information about a potential pathogenic link between a rs39335 SNP and otosclerosis, a case-control study in 92 patients and 92 controls was performed using a restriction enzyme assay for the presence of the polymorphism rs39335, which was one of the more strongly associated SNPs in previous studies [@R16] [@R17], with the G allele frequency higher in otosclerotic subjects than in controls. [Table I](#T1){ref-type="table"} shows the distribution of G allele frequencies in OTSC patients and healthy controls. In the examined population, it was less frequent in otosclerotic subjects than in controls. [Table II](#T2){ref-type="table"} shows the frequencies of the different genotypes (AA, AG, GG) in otosclerotic and control subjects. The AG and GG phenotypes were more frequent in control subjects, while the AA genotype was more frequent in otosclerotic subjects.

###### 

Frequencies of the G allele between otosclerotic patients and control subjects.

  SNP       Position   Sequence change   Frequency in control subjects   Frequency in otosclerotic patients
  --------- ---------- ----------------- ------------------------------- ------------------------------------
  rs39335   28637145   A \> G            42/184 (23%)                    29/184 (16%)

The frequency of the G allele was 16% (29/184 alleles) in otosclerotic individuals compared to controls in which the frequency was 23% (42/184 alleles) ([Table I](#T1){ref-type="table"}). The difference in genotype distribution for the rs39335 SNP did not reach statistical significance (p = 0.0813; OR = 0.626; 95%CI: 0.37-1.07).

Discussion {#S4}
==========

Otosclerosis is a complex disease; although several studies have been carried out, the aetiopathogenesis of otosclerosis remains poorly understood. In the last years, several association studies suggesting that nucleotide variations in some genes may predispose to otosclerosis have been carried out ^11-15^. One of the genes analyzed was *RELN* for which a strong association in French, Belgian-Dutch German, Swiss, Romanian and northern Italian populations was demonstrated [@R14] [@R16] [@R17]. This association was, however, not confirmed in an Indian population [@R18]. Moreover, other data supporting the exclusion of the *RELN* gene as causative for otosclerosis are reported in a recent paper [@R21] where it was shown that this gene does not show active expression in adult stapes footplates.

Confirmatory studies in genotype-phenotype association are important for establishing the credibility of results. In fact, frequently, initial results cannot be confirmed. In this case-control study, both allele ([Table I](#T1){ref-type="table"}) and genotype ([Table II](#T2){ref-type="table"}) distributions of one of the most associated variants in previous works [@R16] [@R17], the SNP rs39335, show no statistically significant association, suggesting that the rs39335 SNP is not a risk factor for otosclerosis.

###### 

Genotype distribution of the *RELN* rs39335 SNP in otosclerotic patients and control subjects.

                Genotype frequency              
  ------------- -------------------- ---------- --------
  **Control**   54 (59%)             34 (37%)   4 (4%)
  **OTSC**      65 (71%)             25 (27%)   2 (2%)

Conclusions {#S5}
===========

The results obtained in this study show that, in the Campania population, there is no association between the rs39335 SNP and otosclerosis. Other variants, however, may still play a role in the disease. Further studies analyzing other variants and additional populations of different ethnic origin would be useful to verify the exact role of *RELN* in development of otosclerosis.
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